Eze-Sit Valvulotome
Payments companies reported to CMS as associated with Eze-Sit Valvulotome. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Eze-Sit Valvulotome, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Eze-Sit Valvulotome
These are the largest totals companies reported as associated with Eze-Sit Valvulotome. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tapash Palit | New Orleans, LA | Vascular Surgery | $42.49 |
| Daniel Badia | Lawrenceville, GA | Vascular Surgery | $20.12 |
| Natalie Sridharan | Pittsburgh, PA | Vascular Surgery | $20.00 |
| Oluwadamilola Ilesanmi | Pittsburgh, PA | Surgery | $19.99 |
| Joel Gotvald | Austin, TX | Vascular Surgery | $19.25 |
| Joseph Dubose | Travis Afb, CA | Surgical Critical Care | $17.97 |
| Augustine Eze | Gastonia, NC | Surgery | $14.50 |
| Allan Capote | Bakersfield, CA | Vascular Surgery | $14.24 |
Prescribed Eze-Sit Valvulotome?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.